Integrative analysis of epigenetic modulation in melanoma cell response to decitabine: clinical implications.

MLA

Halaban, Ruth, et al. “Integrative Analysis of Epigenetic Modulation in Melanoma Cell Response to Decitabine: Clinical Implications.” PloS One, vol. 4, no. 2, 2009, p. e4563. EBSCOhost, https://doi.org/10.1371/journal.pone.0004563.

APA

Halaban, R., Krauthammer, M., Pelizzola, M., Cheng, E., Kovacs, D., Sznol, M., Ariyan, S., Narayan, D., Bacchiocchi, A., Molinaro, A., Kluger, Y., Deng, M., Tran, N., Zhang, W., Picardo, M., & Enghild, J. J. (2009). Integrative analysis of epigenetic modulation in melanoma cell response to decitabine: clinical implications. PloS One, 4(2), e4563. https://doi.org/10.1371/journal.pone.0004563

Chicago

Halaban, Ruth, Michael Krauthammer, Mattia Pelizzola, Elaine Cheng, Daniela Kovacs, Mario Sznol, Stephan Ariyan, et al. 2009. “Integrative Analysis of Epigenetic Modulation in Melanoma Cell Response to Decitabine: Clinical Implications.” PloS One 4 (2): e4563. doi:10.1371/journal.pone.0004563.